Source link : https://www.newshealth.biz/health-news/1-in-5-adults-report-anxiety-depression-new-esketamine-warning-autism-dx-up-175/
One in five adults said they experienced any symptoms of anxiety or depression in a 2-week period, according to a 2022 CDC survey. The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory impairments have been reported with ketamine misuse or abuse. Ketamine was detected in […]
Author : News Health
Publish date : 2024-11-13 18:29:51
Copyright for syndicated content belongs to the linked Source.